Contact us for enquiry
+91 - 880 062 9460

Top Selling
erlonat smart breath temonat lenalid geftinat Veenat
Latest News
Lorem ipsum dolor sit amet, conse faucibus enim

Lorem ipsum dolor sit amet, conse
ctetur adipiscing elit. Duis non faucibus enim

Lorem ipsum dolor sit amet, conse
ctetur adipiscing elit. Duis non faucibus enim faucibus enim.

Geftinat / Gefitinib / Iressa

Geftinat is used for curing non-small cell lung cancer and effectively blocks the action of chemicals which multiply the growth of cancer cells. The medicine is formulated by using gefitinib and basically belongs to a class of anti-cancer medications called epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.

Strength : 250mg tablets
Dosages : Take gefitinib at around the same time every day exactly as directed by Doctor.
Overdose : May lead to:-
  • diarrhea
  • rashes

Precautions & Warnings:

  • Should not be taken without consulting the doctor if the patient ever had pulmonary fibrosis (scarring of the lungs), or liver or kidney disease
  • Not recommended if the patient is allergic to the medicine or any of its constituents
  • Kindly notify the doctor immediately, if allergic reactions (difficulty breathing, closing of the throat, swelling of the lips, tongue, or face; or hives), lung problems, liver problems, eye problems, severe nausea, vomiting, loss of appetite, or diarrhea during treatment are noticed
  • Doctor consultation recommended for pregnant women or for those who are breast feeding their child

Note: Geftinat-Gefitinib / Iressa is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

Drug Interactions:

  • Cimetidine, ranitidine, esomeprazole, lansoprazole, omeprazole
  • Rifampin or phenytoin
  • Ketoconazole, itraconazole, fluconazole, erythromycin, clarithromycin, ritonavir, nelfinavir, indinavir, nefazodone
  • The blood-thinning effects of warfarin may be increased by geftinat and hence, the risk of bleeding may increase